Arteris, Inc. (NASDAQ:AIP - Get Free Report) CEO K Charles Janac sold 1,330 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $8.38, for a total value of $11,145.40. Following the completion of the sale, the chief executive officer now directly owns 327,240 shares of the company's stock, valued at approximately $2,742,271.20. This trade represents a 0.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
K Charles Janac also recently made the following trade(s):
- On Wednesday, March 5th, K Charles Janac sold 1,973 shares of Arteris stock. The shares were sold at an average price of $8.19, for a total value of $16,158.87.
- On Monday, February 3rd, K Charles Janac sold 50,000 shares of Arteris stock. The stock was sold at an average price of $10.33, for a total value of $516,500.00.
- On Monday, January 6th, K Charles Janac sold 8,432 shares of Arteris stock. The stock was sold at an average price of $12.34, for a total value of $104,050.88.
- On Thursday, January 2nd, K Charles Janac sold 6,256 shares of Arteris stock. The stock was sold at an average price of $11.41, for a total transaction of $71,380.96.
- On Monday, December 30th, K Charles Janac sold 58,212 shares of Arteris stock. The stock was sold at an average price of $10.33, for a total transaction of $601,329.96.
- On Thursday, December 26th, K Charles Janac sold 60,584 shares of Arteris stock. The shares were sold at an average price of $10.42, for a total transaction of $631,285.28.
- On Tuesday, December 17th, K Charles Janac sold 14,180 shares of Arteris stock. The stock was sold at an average price of $10.01, for a total value of $141,941.80.
- On Thursday, December 12th, K Charles Janac sold 17,856 shares of Arteris stock. The stock was sold at an average price of $10.12, for a total transaction of $180,702.72.
Arteris Stock Performance
Shares of NASDAQ:AIP traded up $0.01 on Friday, hitting $7.89. 206,807 shares of the company were exchanged, compared to its average volume of 306,116. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.30. The stock's 50 day moving average price is $10.29 and its 200 day moving average price is $8.82. Arteris, Inc. has a 1-year low of $5.76 and a 1-year high of $12.64. The firm has a market capitalization of $323.08 million, a P/E ratio of -9.07 and a beta of 1.21.
Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings data on Tuesday, February 18th. The company reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.08). Arteris had a negative return on equity of 828.71% and a negative net margin of 58.27%. The firm had revenue of $15.49 million for the quarter, compared to analyst estimates of $15.34 million. Sell-side analysts predict that Arteris, Inc. will post -0.73 EPS for the current year.
Hedge Funds Weigh In On Arteris
Institutional investors have recently added to or reduced their stakes in the stock. Needham Investment Management LLC raised its stake in shares of Arteris by 14.7% in the 3rd quarter. Needham Investment Management LLC now owns 2,735,000 shares of the company's stock valued at $21,114,000 after acquiring an additional 350,000 shares during the period. G2 Investment Partners Management LLC purchased a new position in shares of Arteris in the 4th quarter valued at about $2,799,000. Federated Hermes Inc. grew its position in shares of Arteris by 729.4% during the fourth quarter. Federated Hermes Inc. now owns 165,878 shares of the company's stock worth $1,690,000 after buying an additional 145,878 shares in the last quarter. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Arteris during the fourth quarter worth approximately $1,272,000. Finally, EAM Investors LLC acquired a new stake in Arteris in the fourth quarter valued at approximately $983,000. Hedge funds and other institutional investors own 64.36% of the company's stock.
Wall Street Analyst Weigh In
A number of brokerages recently issued reports on AIP. Northland Securities boosted their price target on Arteris from $14.00 to $16.00 and gave the company an "outperform" rating in a report on Wednesday, February 19th. Rosenblatt Securities reaffirmed a "buy" rating and issued a $15.00 price target on shares of Arteris in a research note on Tuesday, February 18th.
View Our Latest Report on AIP
Arteris Company Profile
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
See Also
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
